CoChat

Progress in xenotransplantation: overcoming immune barriers

Open access
Sykes, Megan, Sachs, David H. · 2022 · Nature Reviews Nephrology
Cited by 130

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

A major limitation of organ allotransplantation is the insufficient supply of donor organs. Consequently, thousands of patients die every year while waiting for a transplant. Progress in xenotransplantation that has permitted pig organ graft survivals of years in non-human primates has led to renewed excitement about the potential of this approach to alleviate the organ shortage. In 2022, the first pig-to-human heart transplant was performed on a compassionate use basis, and xenotransplantation experiments using pig kidneys in deceased human recipients provided encouraging data. Many advances in xenotransplantation have resulted from improvements in the ability to genetically modify pigs using CRISPR–Cas9 and other methodologies. Gene editing has the capacity to generate pig organs that more closely resemble those of humans and are hence more physiologically compatible and less prone to rejection. Despite such modifications, immune responses to xenografts remain powerful and multi-faceted, involving innate immune components that do not attack allografts. Thus, the induction of innate and adaptive immune tolerance to prevent rejection while preserving the capacity of the immune system to protect the recipient and the graft from infection is desirable to enable clinical xenotransplantation. This Review summarizes the current state of knowledge regarding immunological barriers to xenotransplantation and discusses the major approaches that are being used to overcome these barriers, including immunosuppression, genetic engineering of pigs and tolerance induction. As the demand for human organs for transplantation far exceeds the supply, many patients die while waiting for a transplant; xenotransplantation provides a potential near-term solution to the organ shortage. Advances in genetic engineering, immunosuppression and tolerance approaches have contributed to improved pig organ survival in non-human primates (NHPs). Functioning pig islet and heart grafts have survived in NHPs for months and functioning pig kidney grafts have survived in NHPs for years. In 2022, a pig heart was transplanted into a patient with heart failure and functioned for 7 weeks and xenotransplantation experiments using pig kidneys in deceased human recipients provided encouraging data. Mixed haematopoietic chimerism and thymic transplantation approaches have been successfully used to tolerize human T cells, B cells and natural killer cells in human immune system mice, providing proof of their potential to induce immune tolerance. Advances in applying tolerance approaches in NHPs, including genetic engineering of source pigs, support their potential to provide a long-term solution to the powerful immune barriers to xenotransplantation. As the demand for human organs for transplantation far exceeds the supply, many patients die while waiting for a transplant; xenotransplantation provides a potential near-term solution to the organ shortage. Advances in genetic engineering, immunosuppression and tolerance approaches have contributed to improved pig organ survival in non-human primates (NHPs). Functioning pig islet and heart grafts have survived in NHPs for months and functioning pig kidney grafts have survived in NHPs for years. In 2022, a pig heart was transplanted into a patient with heart failure and functioned for 7 weeks and xenotransplantation experiments using pig kidneys in deceased human recipients provided encouraging data. Mixed haematopoietic chimerism and thymic transplantation approaches have been successfully used to tolerize human T cells, B cells and natural killer cells in human immune system mice, providing proof of their potential to induce immune tolerance. Advances in applying tolerance approaches in NHPs, including genetic engineering of source pigs, support their potential to provide a long-term solution to the powerful immune barriers to xenotransplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41581-022-00624-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 130

Metadata

Authors
Sykes, M., & Sachs, D. H.
Venue
Nature Reviews Nephrology
Published
2022-10-05
Volume
18
Issue
12
Pages
745-761
ISSN
  • 1745-8323 (ISSN-L)
  • 1759-5061
  • 1759-507X
OpenAlex
W4301603526
Cited by
130
References
1
FWCI
7.58
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progress in xenotransplantation: overcoming immune barriers. https://app.cochat.ai/papers/10.1038/s41581-022-00624-6
The paper
Sykes, M., & Sachs, D. H. (2022). Progress in xenotransplantation: overcoming immune barriers. Nature Reviews Nephrology. https://doi.org/10.1038/s41581-022-00624-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.